Davide Campari-Milano Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Davide Campari-Milano de 14.7% y 7.6% por año respectivamente. Se prevé que el BPA crezca en un 13.1% al año. Se espera que la rentabilidad financiera sea de 12.4% en 3 años.

Información clave

14.6%

Tasa de crecimiento de los beneficios

13.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Beverage	10.2%
Tasa de crecimiento de los ingresos	7.7%
Rentabilidad financiera futura	12.4%
Cobertura de analistas	Good
Última actualización	02 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

It's Probably Less Likely That Davide Campari-Milano N.V.'s (BIT:CPR) CEO Will See A Huge Pay Rise This Year

Apr 05

Davide Campari-Milano N.V.'s (BIT:CPR) Popularity With Investors Is Clear

Mar 30

Investors Appear Satisfied With Davide Campari-Milano N.V.'s (BIT:CPR) Prospects

Dec 27

Returns At Davide Campari-Milano (BIT:CPR) Appear To Be Weighed Down

Dec 15

Does Davide Campari-Milano (BIT:CPR) Have A Healthy Balance Sheet?

Nov 19

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Oct 22

These 4 Measures Indicate That Davide Campari-Milano (BIT:CPR) Is Using Debt Reasonably Well

May 05

Here's What To Make Of Davide Campari-Milano's (BIT:CPR) Decelerating Rates Of Return

Apr 22

Here's Why Davide Campari-Milano N.V.'s (BIT:CPR) CEO Might See A Pay Rise Soon

Apr 07

If EPS Growth Is Important To You, Davide Campari-Milano (BIT:CPR) Presents An Opportunity

Mar 23

Davide Campari-Milano (BIT:CPR) Shareholders Will Want The ROCE Trajectory To Continue

Jan 13

Should You Be Adding Davide Campari-Milano (BIT:CPR) To Your Watchlist Today?

Nov 18

Returns At Davide Campari-Milano (BIT:CPR) Are On The Way Up

Oct 15

Is Davide Campari-Milano (BIT:CPR) A Risky Investment?

Oct 02

Does Davide Campari-Milano (BIT:CPR) Deserve A Spot On Your Watchlist?

Aug 16

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Jul 31

We Think Davide Campari-Milano (BIT:CPR) Can Manage Its Debt With Ease

Jun 22

There's Been No Shortage Of Growth Recently For Davide Campari-Milano's (BIT:CPR) Returns On Capital

Jun 07

Davide Campari-Milano (BIT:CPR) Has A Rock Solid Balance Sheet

Mar 17

Davide Campari-Milano (BIT:CPR) Has Some Way To Go To Become A Multi-Bagger

Feb 28

Here's Why Davide Campari-Milano (BIT:CPR) Can Manage Its Debt Responsibly

Oct 12

Here's What To Make Of Davide Campari-Milano's (BIT:CPR) Decelerating Rates Of Return

Aug 06

Is Davide Campari-Milano (BIT:CPR) A Risky Investment?

Jun 27

Returns On Capital Signal Difficult Times Ahead For Davide Campari-Milano (BIT:CPR)

May 02

Previsiones de crecimiento de beneficios e ingresos

BIT:CPR - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	3,744	552	536	677	17
12/31/2025	3,501	488	261	603	19
12/31/2024	3,176	417	93	472	20
12/31/2023	2,919	331	-159	157	N/A
9/30/2023	2,909	341	-102	185	N/A
6/30/2023	2,899	351	-45	214	N/A
3/31/2023	2,798	342	-10	297	N/A
12/31/2022	2,698	333	25	380	N/A
9/30/2022	2,563	329	90	396	N/A
6/30/2022	2,429	324	155	412	N/A
3/31/2022	2,301	305	246	448	N/A
12/31/2021	2,173	285	338	484	N/A
9/30/2021	2,088	280	306	447	N/A
6/30/2021	2,004	275	274	410	N/A
3/31/2021	1,888	231	233	344	N/A
12/31/2020	1,772	188	193	278	N/A
9/30/2020	1,768	223	195	284	N/A
6/30/2020	1,763	259	197	291	N/A
3/31/2020	1,803	284	234	327	N/A
12/31/2019	1,843	308	271	363	N/A
9/30/2019	1,812	290	245	334	N/A
6/30/2019	1,782	272	218	304	N/A
3/31/2019	1,747	284	231	316	N/A
12/31/2018	1,712	296	245	328	N/A
9/30/2018	1,714	346	243	323	N/A
6/30/2018	1,715	395	242	319	N/A
3/31/2018	1,734	376	233	315	N/A
12/31/2017	1,753	356	225	311	N/A
9/30/2017	1,776	282	N/A	300	N/A
6/30/2017	1,799	208	N/A	289	N/A
3/31/2017	1,763	187	N/A	342	N/A
12/31/2016	1,727	166	N/A	395	N/A
9/30/2016	1,685	166	N/A	415	N/A
6/30/2016	1,643	165	N/A	435	N/A
3/31/2016	1,650	170	N/A	370	N/A
12/31/2015	1,657	175	N/A	305	N/A
9/30/2015	1,644	162	N/A	305	N/A
6/30/2015	1,632	150	N/A	304	N/A
3/31/2015	1,596	139	N/A	294	N/A
12/31/2014	1,560	129	N/A	283	N/A
9/30/2014	1,536	139	N/A	254	N/A
6/30/2014	1,512	150	N/A	226	N/A
3/31/2014	1,518	150	N/A	223	N/A
12/31/2013	1,524	150	N/A	221	N/A
9/30/2013	1,473	143	N/A	226	N/A
6/30/2013	1,421	136	N/A	231	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14.7% al año) de CPR es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (14.7% al año) de CPR crezcan más rápidamente que el mercado Italian (5.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de CPR crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (7.6% al año) de CPR crezcan más rápidamente que los del mercado Italian (3.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.6% al año) de CPR crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de CPR sea baja dentro de 3 años (12.4%).

Davide Campari-Milano Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased to €11.78

Price target increased to €11.34

Consensus EPS estimates increase to €0.27

Recent updates

Davide Campari-Milano N.V. completed the acquisition of Courvoisier S.A.S. from Beam Suntory Inc for approximately €1.2 billion.

Upcoming dividend of €0.065 per share

It's Probably Less Likely That Davide Campari-Milano N.V.'s (BIT:CPR) CEO Will See A Huge Pay Rise This Year

Davide Campari-Milano N.V.'s (BIT:CPR) Popularity With Investors Is Clear

Dividend increased to €0.065

Davide Campari-Milano N.V. signed an agreement to acquire the 100% stake in Courvoisier S.A.S. from Beam Suntory Inc for approximately $1.30 billion.

Full year 2023 earnings: EPS misses analyst expectations

New minor risk - Shareholder dilution

Davide Campari-Milano N.V. announced that it has received €1.200000005 billion in funding

Davide Campari-Milano N.V. announced that it has received €1.200000005 billion in funding

Investors Appear Satisfied With Davide Campari-Milano N.V.'s (BIT:CPR) Prospects

Returns At Davide Campari-Milano (BIT:CPR) Appear To Be Weighed Down

Does Davide Campari-Milano (BIT:CPR) Have A Healthy Balance Sheet?

Executive MD exercised options and sold €926k worth of stock

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching

Executive MD exercised options and sold €2.8m worth of stock

Is Davide Campari-Milano (BIT:CPR) Using Too Much Debt?

Davide Campari-Milano N.V. to Report First Half, 2024 Results on Jul 30, 2024

Returns On Capital At Davide Campari-Milano (BIT:CPR) Have Stalled

First half 2023 earnings released

Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching

Executive MD exercised options and sold €2.7m worth of stock

Executive MD exercised options and sold €82k worth of stock

Campari Pays Homage to Milano Through the Launch of the Iconic New Bottle Inspired by Its Home

These 4 Measures Indicate That Davide Campari-Milano (BIT:CPR) Is Using Debt Reasonably Well

Here's What To Make Of Davide Campari-Milano's (BIT:CPR) Decelerating Rates Of Return

Upcoming dividend of €0.06 per share at 0.5% yield

Here's Why Davide Campari-Milano N.V.'s (BIT:CPR) CEO Might See A Pay Rise Soon

If EPS Growth Is Important To You, Davide Campari-Milano (BIT:CPR) Presents An Opportunity

Executive MD recently sold €660k worth of stock

Executive MD exercised options and sold €470k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Davide Campari-Milano (BIT:CPR) Shareholders Will Want The ROCE Trajectory To Continue

Davide Campari-Milano N.V. to Report Q1, 2023 Results on May 02, 2023

Should You Be Adding Davide Campari-Milano (BIT:CPR) To Your Watchlist Today?

Less than half of directors are independent

Non-Executive Chairman recently bought €1.0m worth of stock

Davide Campari-Milano N.V. (BIT:CPR) agreed to acquire 70% stake in Wilderness Trail Distillery, LLC from Shane Baker and Pat Heist for approximately $420 million.

Davide Campari-Milano N.V. (BIT:CPR) acquired a minority stake in Catalyst Spirits Inc.

Returns At Davide Campari-Milano (BIT:CPR) Are On The Way Up

Is Davide Campari-Milano (BIT:CPR) A Risky Investment?

Espolòn(R) Tequila Unveils Cristalino: an Elevated and Crystal Clear Addition to Their Portfolio

Non-Executive Director recently bought €56k worth of stock

Non-Executive Director recently bought €99k worth of stock

Davide Campari-Milano N.V. (BIT:CPR) acquired 15% stake in Wooler Brands, Inc. from Catalyst Spirits for $115 million.

Does Davide Campari-Milano (BIT:CPR) Deserve A Spot On Your Watchlist?

Non-Executive Director recently bought €52k worth of stock

Non-Executive Chairman recently bought €5.2m worth of stock

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Davide Campari-Milano N.V., Annual General Meeting, Apr 13, 2023

First half 2022 earnings released

Non-Executive Chairman recently bought €8.2m worth of stock

We Think Davide Campari-Milano (BIT:CPR) Can Manage Its Debt With Ease

There's Been No Shortage Of Growth Recently For Davide Campari-Milano's (BIT:CPR) Returns On Capital

Davide Campari-Milano N.V. (BIT:CPR) acquired Picon Brand and Related Assets of Diageo plc (LSE:DGE) for €120 million

Non-Executive Director recently bought €51k worth of stock

Less than half of directors are independent

Upcoming dividend of €0.06 per share

Non-Executive Chairman recently bought €1.9m worth of stock

Non-Executive Chairman recently bought €8.0m worth of stock

Non-Executive Chairman recently bought €6.4m worth of stock

Davide Campari-Milano (BIT:CPR) Has A Rock Solid Balance Sheet

Non-Executive Chairman recently bought €5.4m worth of stock

Non-Executive Director recently bought €95k worth of stock

Davide Campari-Milano (BIT:CPR) Has Some Way To Go To Become A Multi-Bagger

Full year 2021 earnings: Revenues in line with analyst expectations

Price target decreased to €11.78

Davide Campari-Milano N.V. to Report Q1, 2022 Results on May 03, 2022

Here's Why Davide Campari-Milano (BIT:CPR) Can Manage Its Debt Responsibly

Non-Executive Chairman recently bought €746k worth of stock

Executive MD exercised options and sold €2.7m worth of stock